Diagnostic Biomarkers of Oral Leukoplakia: A Brief Review

Authors

  • Maheswari Eluru
  • Kavya B R
  • Jansiya Thangavelu
  • Patil Mukta Sidgonda
  • A. Anitha
  • Renuka

Keywords:

Oral leukoplakia, diagnostic biomarkers, malignant transformation, cytokines, epigenetics, histopathology

Abstract

Oral leukoplakia (OL) is the most prevalent OPMD and carries a significant risk of malignant transformation into OSCC. Although histopathology is the gold standard in diagnosis, it is usually not accurate in predicting the behavior of a lesion, and this aspect highlights the importance of supplementary molecular tools. This review examines the diagnostic potential of the emerging biomarkers, which are genetic, protein-based, epigenetic, salivary, and serum-derived, in evaluating OL progression. Salivary cytokines such as IL-6 and TNF-α, alongside microRNAs and enzymes like ALP and LDH, have shown strong diagnostic potential. Tissue-based markers, including loss of heterozygosity (LOH), DNA ploidy, podoplanin, p27, p53, and Ki-67, provide insights into genetic and proliferative changes associated with malignancy. The potential of these biomarkers is to facilitate more accurate diagnosis, treatment, and prognostic decisions, as well as complement prognostication by regular histology. Further testing and implementation into clinical practice are necessary to maximize OL management and early detection of oral cancer.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, Lequerica-Fernández P, Allonca E, García-Pedrero JM. Podoplanin expression in oral leukoplakia: tumorigenic role. Oral Oncol. 2013 Jun;49(6):598-603. doi: 10.1016/j.oraloncology.2013.02.008. Epub 2013 Mar 7. PMID: 23473850.

Huang, L., Luo, F., Deng, M., & Zhang, J. (2024). The relationship between salivary cytokines and oral cancer and their diagnostic capability for oral cancer: a systematic review and network meta-analysis. BMC oral health, 24(1), 1044. https://doi.org/10.1186/s12903-024-04840-3

Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an literature overview. J Oral Pathol Med. 2008 Jan;37(1):1-10. doi: 10.1111/j.1600-0714.2007.00579.x. PMID: 18154571.

Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, Epstein J, Le ND, Rosin MP. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001 Jun 1;91(11):2148-55. doi: 10.1002/1097-0142(20010601)91:11<2148::aid-cncr1243>3.0.co;2-g. PMID: 11391596.

Bradley, G., Odell, E. W., Raphael, S., Ho, J., Le, L. W., Benchimol, S., & Kamel-Reid, S. (2010). Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. British journal of cancer, 103(9), 1432–1442. https://doi.org/10.1038/sj.bjc.6605905

Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x. PMID: 17944749.

Pinto, A. C., Ribeiro, A. C., Brandão, T. B., Lopes, M. A., & Jorge, J. (2020). Malignant transformation rate of oral leukoplakia—Systematic review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 129(6), 600–611.e2. https://doi.org/10.1016/j.oooo.2020.02.005

Zhou, W., Zhang, S., Hu, Y., Na, J., Wang, N., Ma, X., Yuan, L., & Meng, F. (2015). Meta-analysis of the associations between TNF-α or IL-6 gene polymorphisms and susceptibility to lung cancer. European journal of medical research, 20(1), 28. https://doi.org/10.1186/s40001-015-0113-9 (Retraction published Eur J Med Res. 2016 Aug 02;21(1):31. doi: 10.1186/s40001-016-0225-x.)

Xing RD, Chen RM, Wang ZS, Zhang YZ. Serum sialic acid levels in patients with oral and maxillofacial malignancy. J Oral Maxillofac Surg. 1991 Aug;49(8):843-7. doi: 10.1016/0278-2391(91)90013-c. PMID: 2072195.

Maheswari, T. N. U., Venugopal, A., Sureshbabu, N. M., & Ramani, P. (2018). Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review. Tzu chi medical journal, 30(2), 55–60. https://doi.org/10.4103/tcmj.tcmj_114_17

Goyal G. (2020). Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis. Asian Pacific journal of cancer prevention : APJCP, 21(4), 983–991. https://doi.org/10.31557/APJCP.2020.21.4.983

Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci. 2010 Jun;52(2):251-6. doi: 10.2334/josnusd.52.251. PMID: 20587949.

Singh, V., Patil, R., Singh, S., Tripathi, A., Khanna, V., & Ali, W. (2021). Diagnostic significance of serum and salivary lipid levels in oral precancer and oral cancer. National journal of maxillofacial surgery, 12(2), 188–192. https://doi.org/10.4103/njms.NJMS_268_20

Sharma, D., Thomas, A. M., Kwatra, K. S., Koshy, G., & Mashon, R. S. (2025). Assessment of immune infiltrate in oral cancer: An immunohistochemical study. Journal of oral and maxillofacial pathology : JOMFP, 29(1), 66–75. https://doi.org/10.4103/jomfp.jomfp_184_24

Grochau KJ, Safi AF, Drebber U, Grandoch A, Zöller JE, Kreppel M. Podoplanin expression in oral leukoplakia─a prospective study. J Craniomaxillofac Surg. 2019 Mar;47(3):505-509. doi: 10.1016/j.jcms.2018.12.005. Epub 2018 Dec 13. PMID: 30638740.

Cao, W., Younis, R. H., Li, J., Chen, H., Xia, R., Mao, L., Chen, W., & Ren, H. (2011). EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cancer prevention research (Philadelphia, Pa.), 4(11), 1816–1824. https://doi.org/10.1158/1940-6207.CAPR-11-0130

Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, Warnakulasuriya S, Møller H, Odell EW. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila). 2013 Aug;6(8):822-31. doi: 10.1158/1940-6207.CAPR-13-0001. Epub 2013 Jun 12. PMID: 23761273.

Cheng SJ, Chang CF, Lee JJ, Chen HM, Wang HJ, Liou YL, Yen C, Chiang CP. Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer. Oral Oncol. 2016 Nov;62:34-43. doi: 10.1016/j.oraloncology.2016.09.007. Epub 2016 Oct 6. PMID: 27865370.

Suwasini, S., Chatterjee, K., Purkait, S. K., Samaddar, D., Chatterjee, A., & Kumar, M. (2018). Expression of P53 Protein and Ki-67 Antigen in Oral Leukoplakia with Different Histopathological Grades of Epithelial Dysplasia. Journal of International Society of Preventive & Community Dentistry, 8(6), 513–522. https://doi.org/10.4103/jispcd.JISPCD_241_18

Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000 Feb;6(2):357-62. PMID: 10690511.

Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol. 2001 Jul;194(3):294-7. doi: 10.1002/1096-9896(200107)194:3<294::AID-PATH911>3.0.CO;2-Q. PMID: 11439360.

Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016 Mar;45(3):155-66. doi: 10.1111/jop.12339. Epub 2015 Jul 20. PMID: 26189354.

Zhang, L., Poh, C. F., Williams, M., Laronde, D. M., Berean, K., Gardner, P. J., Jiang, H., Wu, L., Lee, J. J., & Rosin, M. P. (2012). Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer. Cancer prevention research (Philadelphia, Pa.), 5(9), 1081–1089. https://doi.org/10.1158/1940-6207.CAPR-12-0173

Downloads

Published

2025-06-27

How to Cite

1.
Eluru M, B R K, Thangavelu J, Sidgonda PM, Anitha A, Renuka R. Diagnostic Biomarkers of Oral Leukoplakia: A Brief Review. J Neonatal Surg [Internet]. 2025Jun.27 [cited 2025Jul.20];14(32S):2419-25. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7758

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.